WallStSmart
KPRX

Kiora Pharmaceuticals Inc

NASDAQ: KPRX · HEALTHCARE · BIOTECHNOLOGY

$0.72
-12.28% today

Updated 2026-11-20

Market cap
$4.12M
P/E ratio
—
P/S ratio
4.12x
EPS (TTM)
$-2.46
Dividend yield
—
52W range
$1 – $3
Volume
0.0M

Kiora Pharmaceuticals Inc (KPRX) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price
$0.72
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—

Financial forecast

Metric20212022202320242025
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B
EPS—————
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.